
In case you missed any, read a recap of the episodes of OncLive On Air that aired in October 2026.
Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.
The FDA granted accelerated approval to neladalkib (Nelkarmi) for locally advanced or metastatic ALK-positive non–small cell lung cancer based on data from the phase 1/2 ALKOVE-1 trial (NCT05384626). Patients previously treated with which single ALK-directed TKI are included in the indication?





